Profil
Howard J.
Franklin worked as Chief Medical Officer at Salix Pharmaceuticals Ltd. from 2018 to 2022.
Also worked as Chief Medical Officer at Finch Therapeutics Group, Inc. Worked as Senior Vice President-Medical at Assertio Holdings, Inc. from 2023 to 2026.
Education includes a doctorate from Drexel University College of Medicine, an undergraduate degree from Lehigh University, and an MBA from LaSalle University.
Anciens postes connus de Howard Franklin
| Sociétés | Poste | Fin |
|---|---|---|
| ASSERTIO HOLDINGS | Directeur Technique/Scientifique/R&D | 16/06/2026 |
| SALIX PHARMACEUTICALS, LTD. | Directeur Technique/Scientifique/R&D | 01/03/2022 |
| FINCH THERAPEUTICS GROUP, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Howard Franklin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Salix Pharmaceuticals Ltd.
Salix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops prescription drugs | Health Technology |
LaSalle University
LaSalle University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lehigh University
Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Drexel University College of Medicine
Drexel University College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Finch Therapeutics Group, Inc.
Finch Therapeutics Group, Inc. Medical/Nursing ServicesHealth Services Provides microbial therapy services | Health Services |
Assertio Holdings, Inc.
Assertio Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
















